Patent Assignment
Reel/Frame 048148/0718
Change of Name
Recorded: 2018-11-20
Pages: 3
Assignor
ZENITH EPIGENETICS CORP.
Executed: 2016-08-01
Assignee
ZENITH CAPITAL CORP.
500, 4820 RICHARD ROAD SW, CALGARY, AB, T3E 6L1, CANADA
Covered Property
(1)
Novel Bicyclic Bromodomain Inhibitors
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 20, 2018
From: QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; LIU, SHUANG; WANG, RUIFANG
To: RVX THERAPEUTICS INC.
Reel/Frame 047552/0613 →
General Conveyance and Assumption Agreement
Nov 20, 2018
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP,
Reel/Frame 047605/0756 →
Assignment of Assignor's Interest
Nov 20, 2018
From: QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; LIU, SHUANG; WANG, RUIFANG
To: ZENITH EPIGENETICS CORP.
Reel/Frame 047605/0785 →
Assignment of Assignor's Interest
Nov 20, 2018
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 048148/0736 →